Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and gemcitabine in advanced breast cancer
NCT00470249Phase 2Terminated
- Sponsor
- University of Southampton
- Start
- Jul 2006
- Primary completion
- Nov 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, gemcitabine in breast cancer, sponsored by University of Southampton. Started Jul 2006; status: terminated.
02
Drugs
carboplatingemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00470249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00470249.